Tech Company Financing Transactions
PhageTech Funding Round
PhageTech, based in ?Irvine, secured $2.4 million from Black River Asset Management and Mark IV Capital.
Transaction Overview
Company Name
Announced On
9/30/2015
Transaction Type
Venture Equity
Amount
$2,400,000
Round
Series A
Investors
Black River Asset Management (Lead Investor)
Mark IV Capital (Lead Investor)
Proceeds Purpose
Proceeds will be used to complete development and FDA clearance of its revolutionary PhageTech Biosensor technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5151 California Ave. 150
?Irvine, CA 92617
USA
?Irvine, CA 92617
USA
Phone
Undisclosed
Website
Email Address
Overview
PhageTech, Inc. is a California based development stage company with an innovative platform that employs a bacteriophage substrate for detecting analytes in urine, blood and most any other body fluid. This technology promises to offer equal or better performance against antibody based assays.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Paul Cate
Chief Executive Officer
Reuben Richards
Co-Founder
Richard Henson
Co-Founder
Gregory Weiss
Browse more venture capital transactions:
Prev: 9/30/2015: Symbiont venture capital transaction
Next: 9/30/2015: Avant venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs